secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0001493152-21-032413
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic Therapeutics dismisses Baker Tilly, hires Rose Snyder & Jacobs as auditor
--------------------------------------------------------------------------------

- Baker Tilly's reports for FY 2020 and 2019 contained a going-concern emphasis paragraph.
- No disagreements or reportable events occurred with Baker Tilly during the relevant periods.
- New auditor RSJ was engaged effective December 21, 2021 for FY 2021 audit.
- Company did not consult RSJ on any accounting or auditing matters prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315221032413/0001493152-21-032413-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315221032413/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032413

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer